State of Tech in Biopharma Report As biopharma races toward delivering medicines faster, it’s adopting cloud tech, AI / ML, and robotics to improve R&D productivity. This report surveys over 300 biopharma experts — across R&D and IT functions — to understand usage, impact, and challenges biopharma faces in adoption. Respondent demographics included: 59% of the respondents represented R&D (including data science), while 41% represented IT, digital, or informatics 58% working in the industry for 7 or more years 66% with seniority roles of manager level or above Read the full report for more findings on how biopharma is adopting enabling technology to reach critical R&D milestones faster. © Copyright 2024 Benchling. All Rights Reserved. Complete this form todownload the report State of Tech in Biopharma Report First NameLast NameJob TitleEmail AddressPhone Company Name By accessing this resource, you agree that Benchling may contact you by phone and/or email about products, services, and offers that may be of interest to you. You may unsubscribe at any time. Download now
